Randomized Clinical Trials in Rectal and Anal Cancers

Surgical Oncology Clinics of North America

Volumn 19, Issue 1, 2010, Pages 205-223

  Park, Jason ^a   Neuman, Heather B ^a   Weiser, Martin R ^a   Wong, W Douglas ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Anal cancer; Chemotherapy; Radiation; Randomized trials; Rectal cancer; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; TEGAFUR; URACIL;

ANASTOMOSIS LEAKAGE; ANOPLASTY; ANUS CANCER; BLOOD TOXICITY; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLOSTOMY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MINIMALLY INVASIVE SURGERY; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PREOPERATIVE RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RECTUM SURGERY; REVIEW; STOMA; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANUS NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS;

EID: 70449440965     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.09.005     Document Type: Review

References (89)

1. Nissan A., Dangelica M.I., Shoup M.C., et al. Randomized clinical trials in rectal and anal cancer. Surg Oncol Clin N Am 11 (2002) 149-172
2. Ferulano G.P., Dilillo S., La Manna S., et al. Influence of the surgical treatment on local recurrence of rectal cancer: a prospective study (1980-1992). J Surg Oncol 74 (2000) 153-157
3. Moore H.G., Riedel E., Minsky B.D., et al. Adequacy of 1 cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 10 (2003) 80-85
4. Paty P.B., Enker W.E., Cohen A.M., et al. Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg 219 (1994) 365-373
5. Lazorthes F., Chiotasso P., Gamagami R.A., et al. Late clinical outcome in a randomized prospective comparison of colonic J pouch and straight coloanal anastomosis. Br J Surg 84 (1997) 1449-1451
6. Hallbook O., Pahlman L., Krog M., et al. Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection. Ann Surg 224 (1996) 58-65
7. Enker W.E., Thaler H.T., Cranor M.L., et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181 (1995) 335-346
8. MacFarlane J.K., Ryall R.D., and Heald R.J. Mesorectal excision for rectal cancer. Lancet 341 (1993) 457-460
9. Heald R.J., and Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1 (1986) 1479-1482
10. Guillou P.J., Quirke P., Thorpe H., et al. Short-term end points of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365 (2005) 1718-1726
11. Jayne D.G., Guillou P.J., Thorpe H., et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25 (2007) 3061-3068
12. Jayne D.G., Brown J.M., Thorpe H., et al. Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg 92 (2005) 1124-1132
13. Zhou Z.G., Hu M., Li Y., et al. Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc 18 (2004) 1211-1215
14. Braga M., Frasson M., Vignali A., et al. Laparoscopic resection in rectal cancer patients: outcome and cost-benefit analysis. Dis Colon Rectum 50 (2007) 464-471
15. Braga M., Vignali A., Zuliani W., et al. Laparoscopic versus open colorectal surgery: cost-benefit analysis in a single-center randomized trial. Ann Surg 242 (2005) 890-895
16. Arteaga González I., Díaz Luis H., Martín Malagón A., et al. A comparative clinical study of short-term results of laparoscopic surgery for rectal cancer during the learning curve. Int J Colorectal Dis 21 (2006) 590-595
17. Ng S.S., Leung K.L., Lee J.F., et al. Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: a prospective randomized trial. Ann Surg Oncol 15 (2008) 2418-2425
18. Lezoche E., Guerrieri M., Paganini A.M., et al. Transanal endoscopic versus total mesorectal laparoscopic resections of T2-N0 low rectal cancers after neoadjuvant treatment: a prospective randomized trial with a 3-years minimum follow-up period. Surg Endosc 19 (2005) 751-756
19. Lezoche G., Baldarelli M., Guerrieri M., et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 22 (2008) 352-358
20. Winde G., Nottberg H., Keller R., et al. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum 39 (1996) 969-976
21. Paty P.B., Nash G.M., Baron P., et al. Long-term results of local excision for rectal cancer. Ann Surg 236 (2002) 522-529
22. Bentrem D.J., Okabe S., Wong W.D., et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery?. Ann Surg 242 (2005) 472-477
23. Nash G.M., Weiser M.R., Guillem J.G., et al. Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum 52 (2009) 577-582
24. Garcia-Aguilar J., Mellgren A., Sirivongs P., et al. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg 231 (2000) 345-351
25. Fazio V.W., Zutshi M., Remzi F.H., et al. A randomized multicenter trial to compare long-term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers. Ann Surg 246 (2007) 481-488
26. Liang J.T., Lai H.S., Lee P.H., et al. Comparison of functional and surgical outcomes of laparoscopic-assisted colonic J-pouch versus straight reconstruction after total mesorectal excision for lower rectal cancer. Ann Surg Oncol 14 (2007) 1972-1979
27. Park J.G., Lee M.R., Lim S.B., et al. Colonic J-pouch anal anastomosis after ultralow anterior resection with upper sphincter excision for low-lying rectal cancer. World J Gastroenterol 11 (2005) 2570-2573
28. Sailer M., Fuchs K.H., Fein M., et al. Randomized clinical trial comparing quality of life after straight and pouch coloanal reconstruction. Br J Surg 89 (2002) 1108-1117
29. Furst A., Burghofer K., Hutzel L., et al. Neorectal reservoir is not the functional principle of the colonic J-pouch: the volume of a short colonic J-pouch does not differ from a straight coloanal anastomosis. Dis Colon Rectum 45 (2002) 660-667
30. Oya M., Komatsu J., Takase Y., et al. Comparison of defecatory function after colonic J-pouch anastomosis and straight anastomosis for stapled low anterior resection: results of a prospective randomized trial. Surg Today 32 (2002) 104-110
31. Ho Y.H., Seow-Choen F., and Tan M. Colonic J-pouch function at six months versus straight coloanal anastomosis at two years: randomized controlled trial. World J Surg 25 (2001) 876-881
32. Jiang J.K., Yang S.H., and Lin J.K. Transabdominal anastomosis after low anterior resection: a prospective, randomized, controlled trial comparing long-term results between side-to-end anastomosis and colonic J-pouch. Dis Colon Rectum 48 (2005) 2100-2108
33. Machado M., Nygren J., Goldman S., et al. Functional and physiologic assessment of the colonic reservoir or side-to-end anastomosis after low anterior resection for rectal cancer: a two-year follow-up. Dis Colon Rectum 48 (2005) 29-36
34. Machado M., Nygren J., Goldman S., et al. Similar outcome after colonic pouch and side-to-end anastomosis in low anterior resection for rectal cancer: a prospective randomized trial. Ann Surg 238 (2003) 214-220
35. Furst A., Suttner S., Agha A., et al. Colonic J-pouch vs. coloplasty following resection of distal rectal cancer: early results of a prospective, randomized, pilot study. Dis Colon Rectum 46 (2003) 1161-1166
36. Ulrich A.B., Seiler C.M., Z'graggen K., et al. Early results from a randomized clinical trial of colon J-pouch versus transverse coloplasty pouch after low anterior resection for rectal cancer. Br J Surg 95 (2008) 1257-1263
37. Pimentel J.M., Duarte A., Gregorio C., et al. Transverse coloplasty pouch and colonic J-pouch for rectal cancer-a comparative study. Colorectal Dis 5 (2003) 465-470
38. Chude G.G., Rayate N.V., Patris V., et al. Defunctioning loop ileostomy with low anterior resection for distal rectal cancer: should we make an ileostomy as a routine procedure? A prospective randomized study. Hepatogastroenterology 55 (2008) 1562-1567
39. Matthiessen P., Hallbook O., Rutegard J., et al. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg 246 (2007) 207-214
40. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet 348 (1996) 1605-1610
41. Fisher B., Wolmark N., Rockette H., et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80 (1988) 21-29
42. Roswit B., Higgins G.A., and Keehn R.J. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a national Veterans Administration randomized study. Cancer 35 (1975) 1597-1602
43. Reis Neto J.A., Quilici F.A., and Reis Jr. J.A. A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial. Dis Colon Rectum 32 (1989) 702-710
44. Folkesson J., Birgisson H., Pahlman L., et al. Swedish Rectal Cancer Trial: long-lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23 (2005) 5644-5650
45. Cedermark B., Johansson H., Rutqvist L.E., et al. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 75 (1995) 2269-2275
46. Gerard A., Buyse M., Nordlinger B., et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 208 (1988) 606-614
47. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 358 (2001) 1291-1304
48. Pahlman L., and Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 211 (1990) 187-195
49. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
50. Peeters K.C., Marijnen C.A., Nagtegaal I.D., et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246 (2007) 693-701
51. Martling A., Holm T., Johansson H., et al. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 92 (2001) 896-902
52. Holm T., Johansson H., Rutqvist L.E., et al. Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer. Br J Surg 88 (2001) 839-843
53. Marijnen C.A., Kapiteijn E., van de Velde C.J., et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 20 (2002) 817-825
54. Birgisson H., Pahlman L., Gunnarsson U., et al. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 95 (2008) 206-213
55. Birgisson H., Pahlman L., Gunnarsson U., et al. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23 (2005) 8697-8705
56. Lange M.M., den Dulk M., Bossema E.R., et al. Risk factors for faecal incontinence after rectal cancer treatment. Br J Surg 94 (2007) 1278-1284
57. Marijnen C.A., van de Velde C.J., Putter H., et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23 (2005) 1847-1858
58. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
59. Sauer R., Fietkau R., Wittekind C., et al. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis 5 (2003) 406-415
60. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 (2006) 1215-1223
61. Bujko K., Nowacki M.P., Kepka L., et al. Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs chemoradiation. Colorectal Dis 7 (2005) 410-416
62. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72 (2004) 15-24
63. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan. Jpn J Clin Oncol 25 (1995) 91-103
64. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 312 (1985) 1465-1472
65. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324 (1991) 709-715
66. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264 (1990) 1444-1450
67. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
68. Bosset J.F., Calais G., Mineur L., et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J Clin Oncol 23 (2005) 5620-5627
69. Bosset J.F., Calais G., Daban A., et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 40 (2004) 219-224
70. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
71. Frykholm G.J., Pahlman L., and Glimelius B. Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 50 (2001) 427-434
72. Braendengen M., Tveit K.M., Berglund A., et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 26 (2008) 3687-3694
73. Gray R., Barnwell J., McConkey C., et al., Quasar Collaborative Group. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370 (2007) 2020-2029
74. Taal B.G., Van Tinteren H., and Zoetmulder F.A. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer 85 (2001) 1437-1443
75. Minsky B.D., and Guillem J.G. Multidisciplinary management of resectable rectal cancer. New developments and controversies. Oncology (Williston Park) 22 (2008) 1430-1437
76. Akasu T., Moriya Y., Ohashi Y., et al. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Jpn J Clin Oncol 36 (2006) 237-244
77. Kato T., Ohashi Y., Nakazato H., et al. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial. Langenbecks Arch Surg 386 (2002) 575-581
78. Nordlinger B., Rougier P., Arnaud J.P., et al. Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial. Lancet Oncol 6 (2005) 459-468
79. Smalley S.R., Benedetti J.K., Williamson S.K., et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24 (2006) 3542-3547
80. Tsavaris N., Gennatas K., Kosmas C., et al. Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer. Oncol Rep 12 (2004) 927-932
81. De Placido S., Lopez M., Carlomagno C., et al. Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study. Br J Cancer 93 (2005) 896-904
82. de la Torre A., Garcia-Berrocal M.I., Arias F., et al. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin. Int J Radiat Oncol Biol Phys 70 (2008) 102-110
83. Nigro N.D., Seydel H.G., Considine B., et al. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51 (1983) 1826-1829
84. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Coordinating Committee on Cancer Research. Lancet 348 (1996) 1049-1054
85. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
86. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
87. Ajani J.A., Winter K.A., Gunderson L.L., et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299 (2008) 1914-1921
88. Tournier-Rangeard L., Mercier M., Peiffert D., et al. Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03). Radiother Oncol 87 (2008) 391-397
89. Kouloulias V., Plataniotis G., Kouvaris J., et al. Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol 28 (2005) 91-99